Vertex Pharmaceuticals (VRTX) Return on Capital Employed Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -917.00 |
| Dec 31, 2025 | -1,009.00 |
| Sep 30, 2025 | -1,041.00 |
| Jun 30, 2025 | -663.00 |
| Mar 31, 2025 | -2,714.00 |
| Dec 31, 2024 | -1,943.00 |
| Sep 30, 2024 | -1,472.00 |
| Jun 30, 2024 | -1,780.00 |
| Mar 31, 2024 | 666.00 |
| Dec 31, 2023 | 579.00 |
| Sep 30, 2023 | 407.00 |
| Jun 30, 2023 | 2,116.00 |
| Mar 31, 2023 | 2,668.00 |
| Dec 31, 2022 | 2,452.00 |
| Sep 30, 2022 | 2,921.00 |
| Jun 30, 2022 | 1,917.00 |
| Mar 31, 2022 | 1,303.00 |
| Dec 31, 2021 | 2,506.00 |
| Sep 30, 2021 | 2,972.00 |
| Jun 30, 2021 | 2,906.00 |
| Mar 31, 2021 | 4,620.00 |
| Dec 31, 2020 | 5,342.00 |
| Sep 30, 2020 | 5,834.00 |
| Jun 30, 2020 | 6,063.00 |
| Mar 31, 2020 | 5,651.00 |
| Dec 31, 2019 | 5,278.00 |
| Sep 30, 2019 | 4,220.00 |
| Jun 30, 2019 | 4,548.00 |
| Mar 31, 2019 | 3,587.00 |
| Dec 31, 2018 | 4,444.00 |
| Sep 30, 2018 | 4,931.00 |
| Jun 30, 2018 | 2,949.00 |
| Mar 31, 2018 | 2,327.00 |
| Dec 31, 2017 | 470.00 |
| Sep 30, 2017 | -1,200.00 |
| Jun 30, 2017 | -1,101.00 |
| Mar 31, 2017 | -722.00 |
| Dec 31, 2016 | -593.00 |
| Mar 31, 2016 | 4,129.00 |
| Dec 31, 2015 | 2,843.00 |
| Sep 30, 2015 | 1,838.00 |
| Jun 30, 2015 | 1,031.00 |
| Mar 31, 2015 | 380.00 |